News
The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded ...
Strand Therapeutics has raised $153 million in second-round financing that will be used to move its programmable mRNA ...
A new pediatric brain cancer treatment uses a short RNA strand to shut down a deadly mutation. Introducing into a cell an exact match for a mutant protein’s mRNA, called an antisense oligonucleotide ...
New research shows modifying noncoding RNA with N6-methyladenosine allows the RNA exosome to recognize a specific noncoding RNA associated with the genomic site that encodes the heavy chain of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results